Major biologics to lose patent protection 2015-2020 by EU5 and U.S. revenue

Published by Statista Research Department, Sep 8, 2016
This statistic shows the major biologics scheduled to lose patent protection between 2015 and 2020, by combined EU-5 and U.S. revenue, in billion euros. Adalimumab will lose its patent protection by 2018. This drug is generating over 10 billion euros of revenue annually. Biologicals which lose their patent protection are potentials for the biosimilars market.

Major biologics scheduled to lose patent protection between 2015 and 2020, by combined EU-5 and U.S. revenue (in billion euros)*

CharacteristicRevenue in billion euros
- -
- -
- -
- -
- -
- -
- -
- -
Showing entries 1 to 8 (8 entries in total)
Statistic: Major biologics scheduled to lose patent protection between 2015 and 2020, by combined EU-5 and U.S. revenue (in billion euros)*

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2016

Region

United States, EU

Survey time period

as of December 2015

Supplementary notes

* All sales figures are for MAT September 2015. EU-5 includes Germany, UK, France, Italy, and Spain.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Leading companies

6

International trade

6

Research and development

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in RomaniaSanofiBiotechnology in SpainBiotech drugsPfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.